NEWS

WIRES

OTHER

Cord Blood America Announces Acquisition of RainMakers International, Inc.

Cord Blood America, Inc. , parent company of Cord Partners, a family cord blood preservation company, announced today that it has acquired RainMakers International, Inc., of Los Angeles, CA. RainMakers International provides direct response advertising for family-based products and services. Details of the acquisition are below.

This acquisition adds the RainMakers International property to the family of Cord Blood America companies. Joseph Vicente, a Director of Cord Blood America, will become President of RainMakers International, Inc.

Matthew L. Schissler, Chairman & CEO of Cord Blood America, states, "Adding RainMakers' marketing knowledge and developing our own in-house marketing firm will allow us to better position our organization in front of expecting families. We feel this is a big win for Cord Blood America." RainMakers International commenced operations in March 2001.

About Cord Blood America

Cord Blood America is the parent company of Cord Partners, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Cord Blood America, Inc. (CBAI) trades on the OTC BB, alongside Cryo-Cell, Inc. (CCEL), another umbilical cord blood company. A third one, Viacell, Inc. (VIAC), trades on the NASDAQ. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and life-saving resource for treating a growing number of ailments. For more information on how this precious lifeline can benefit your family, visit . For investor information, visit www.cordblood-america.com.

In addition to meeting the new Food and Drug Administration (FDA) standards that will take effect in May 2005, Cord Partners' partner laboratory holds the following licenses and certificates of accreditation:

--  Health Care Finance Administration Certificate (Clinical Laboratory
    Improvement Act of 1988)
--  Nuclear Regulatory Commission License Accreditation by the American
    Association of Blood Banks
--  Accreditation by the American Society of Histocompatibility and
    Immunogenetics
--  New Jersey State Department of Health Clinical Laboratory and Blood
    Bank licenses
--  New York State Department of Health licenses for collection, testing
    processing and distribution of donated blood and blood products.
--  Licensed by PharmaStem Therapeutics, the organization that holds the
    patents to stem cell preservation techniques.
    

About the acquisition of RainMakers International

On February 28, 2005, Cord Blood America, Inc. acquired all of the issued and outstanding shares of common stock of Career Channel, Inc., also known as RainMakers International, Inc. ("RainMakers International"). RainMakers International is engaged in the advertising business.

The purchase price for all of the issued and outstanding shares of RainMakers International was 3,656,000 shares of common stock of Cord Blood America, Inc. Matthew L. Schissler, the Chairman of the Board and Chief Executive Officer of Cord Blood America, Inc., and Stephanie A. Schissler, the President and Chief Operating Officer of Cord Blood America, Inc., were, prior to the acquisition, the controlling shareholders of RainMakers International.

The members of the Board of Directors of Cord Blood America, Inc., excluding Mr. Schissler, determined the purchase price for the shares of common stock of RainMakers International based upon an analysis of various financial criteria of comparable publicly traded advertising companies, including multiples of revenues and net income. The members of the Board of Directors of Cord Blood America, Inc., excluding Mr. Schissler, then determined the number of shares of common stock of Cord Blood America, Inc. to be issued based upon the average of the closing bid and ask prices of the shares of common stock of Cord Blood America, Inc. on February 25, 2005.

Forward-Looking Statements

This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. Forward-looking statements include, without limitation, our ability to increase income streams, to grow revenue and earnings, and to obtain additional cord blood banking revenue streams. These statements are only predictions and are subject to certain risks, uncertainties and assumptions, which are identified and described in the Company's public filings with the Securities and Exchange Commission.

Distributed by Market Wire